Trypanosoma cruzi: Chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area

Experimental Parasitology

Volumn 111, Issue 2, 2005, Pages 80-86

  Rivarola, H W ^a   Bustamante, J M ^a   Lo Presti, S ^a   Fernandez A R ^b   Enders, J E ^a   Gea, S ^c   Fretes, R ^c   Paglini Oliva, P ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Chagas' disease treatment; Clomipramine; T. cruzi strains

Indexed keywords

ANTITRYPANOSOMAL AGENT; BETA ADRENERGIC RECEPTOR; CALMODULIN INHIBITOR; CLOMIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPANOTHIONE REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGENTINA; ARTICLE; CHAGAS DISEASE; CHEMOTHERAPY; CHRONIC DISEASE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; ELECTROCARDIOGRAM; ENDEMIC DISEASE; EXPERIMENTAL INFECTION; HEART FUNCTION; MALE; MOUSE; MYOCARDIAL DISEASE; NONHUMAN; PARASITE ISOLATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SURVIVAL; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

TRYPANOSOMA CRUZI;

EID: 24644484011     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2005.05.005     Document Type: Article

References (35)

1. S.G. Andrade Trypanosoma cruzi: clonal structure of parasite strains and the importance of principal clones Memorias do Instituto Oswaldo Cruz 94 1999 185 187
2. S.R. Barioglio, J.L. Lacuara, and P. Paglini-Oliva Effects of clomipramine upon motility of Trypanososma cruzi Journal of Parasitology 73 1987 451 452
3. B. Bondy Recent trends in the field of calmodulin inhibitors J. Barbé H. Keyser J.C. Soyfer Biological and chemical aspects of thiazides and analogs vol. 1 1995 English Associated San Gabriel, CA 433 434
4. E. Borda, J. Pascual, P. Cossio, M. Vega, R.M. Arana, and L. Sterin-Borda A circulating IgG in Chagas' disease which binds to β adrenoceptor of myocardium and modulates its activity Clinical and Experimental Immunology 57 1984 679 686
5. O.E. Brodde B-Adrenergic receptors in failing human myocardium Basic Research in Cardiology 91 1996 35 40
6. J.M. Bustamante, H.W. Rivarola, A.R. Fernández, J.E. Enders, R. Fretes, G. De Luca d'Oro, J.A. Palma, and P.A. Paglini-Oliva Trypanosoma cruzi reinfections provoke synergistic effect and cardiac β-adrenergic receptor dysfunction in the acute phase of experimental Chagas' disease Experimental Parasitology 103 2003 136 142
7. J.A. Castro Contributions of toxicology to the problem of Chagas' disease (American trypanosomiasis). A year 2000 update Biomedical Environment Science 13 2000 271 279
8. J.E. Enders, P. Paglini, A.R. Fernández, F. Marco, and J.A. Palma Cardiac Beta receptor in experimental Chagas disease Revista del Instituto de Medicina Tropical de Sao Paulo 37 1995 59 62
9. A.R. Fernández, J.E. Enders, H.W. Rivarola, P. Paglini, and J.A. Palma Cardiac β receptors' density or affinity modified by different Trypanosoma cruzi amount Acta Physiologica Pharmacologica et Therapeutica Latinoamericana 47 1996 137 143
10. L.S. Filardi, and Z. Brener Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease Transactions of the Royal Society of Tropical Medicine and Hygiene 81 1987 755 759
11. S. Gea, A. Gruppi, F. Cerbán, M.C. Pistoresi-Palencia, and E. Vottero-Cima Immune response in mice immunized with acidic antigenic fractions from Trypanosoma cruzi cytosol Revista del Instituto de Medicina Tropical de Sao Paulo 34 1992 389 394
12. N. Girones, and M. Fresno Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends in Parasitology 19 2003 19 22
13. J. Gutierrez-Correa, A.H. Fairlamb, and O.M. Stoppani Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase-generated phenothiazine cation radicals Free Radical Research 34 2001 363 378
14. M. Higuchi, L.A. Benvenuti, M.M. Reis, and M. Metzger Pathophysiology of the heart in Chagas' disease: current status and new developments Cardiovascular Research 60 2003 96 107
15. C. Hopkins Sibley, and S.Y. Hunt Drug resistance in parasites: can we stay ahead of the evolutionary curve? Trends in Parasitology 19 2003 532 537
16. C. Labriola, M. Sousa, and J.J. Cazzulo Purification of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi by affinity chromatography Biological Research 26 1993 101 107
17. M.S. Lo Presti, H.W. Rivarola, J.M. Bustamante, A.R. Fernández, J.E. Enders, R. Fretes, S. Gea, and P.A. Paglini-Oliva Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice International Journal of Antimicrobial Agents 23 2004 634 636
18. A.M. Macedo, and S.D.J. Pena Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease Parasitology Today 14 1998 119 124
19. C.A. Machado, and F.J. Ayala Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi Proceedings of the National Academy of Science of the United States of America 98 2001 7396 7401
20. M.H. Magdesian, R. Giordano, H. Ulrich, M. Juliano, L. Juliano, R.I. Schumacher, W. Colli, and M.J. Alves Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor Journal of Biological Chemistry 276 2001 19382 19389
21. E.E. Montamat, G.M. De Luca D'oro, R.H. Galerano, R. Sosa, and A. Blanco Characterization of Trypanosoma cruzi population by zymodemes: correlation with clinical picture American Journal of Tropical Medicine and Hygiene 55 1996 625 628
22. S.M.F. Murta, R.T. Gazzinelli, Z. Brener, and A.J. Romanha Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox Molecular and Biochemical Parasitology 93 1998 203 214
23. S.M.F. Murta, and A.J. Romanha In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole Parasitology 116 1998 165 171
24. S.M.F. Murta, and A.J. Romanha Characterization of Trypanosoma cruzi Memorias do Instituto Oswaldo Cruz 94 1999 177 180
25. P. Paglini-Oliva, A.R. Fernández, R. Fretes, and A. Pelsman Structural, ultrastructural studies and evolution of Trypanosoma cruzi infected mice treated with thioridazine Experimental and Molecular Pathology 65 1998 78 86
26. S. Revollo, B. Oury, and J.P. Laurent Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties Experimental Parasitology 89 1998 30 39
27. H.W. Rivarola, A.R. Fernandez, J.E. Enders, S. Gea, R. Fretes, and P. Paglini-Oliva Effects of clomipramine on Trypanosoma cruzi infection in mice Transactions of the Royal Society of Tropical Medicine and Hygiene 95 2001 529 533
28. H.W. Rivarola, and P.A. Paglini-Oliva Tripanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas' disease evolution Current Drug Target-Cardiovascular and Haematological Disorders 2 2002 43 52
29. H.W. Rivarola, A.R. Fernandez, J.E. Enders, S. Gea, J.A. Palma, and P. Paglini-Oliva Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice Annals of Tropical Medicine and Parasitology 93 1999 695 702
30. J. Rodrígues Coura, and S. de Castro A critical review on Chagas disease chemotherapy Memorias do Instituto Oswaldo Cruz 97 2002 3 24
31. M.A. Segura, E. Molina de Raspi, and M.A. Basombrio Reversibility of muscle and heart lesions in chronic, Tripanosoma cruzi infected mice after late trypanocidal treatment Memorias do Instituto Oswaldo Cruz 89 1994 213 216
32. M.A. Segura, L.C. Barberá, F. Ramos, and M.A. Basombrio Regression of antibodies and resistance to reinfection in mice inoculated with an attenuated Trypanosoma cruzi strain and treated with nifurtimox Memorias do Instituto Oswaldo Cruz 91 1996 316
33. L. Sterin-Borda, G. Goselik, M. Postan, S.M. González-Cappa, and E. Borda Alteration in cardiac beta-adrenergic receptors in chagasic mice and their associations with circulating beta-adrenoceptor-related autoantibodies Cardiovascular Research 41 1999 116
34. R.L. Tarleton Chagas disease: a role for autoimmunity Trends in Parasitology 19 2003 447 451
35. V.M. Veloso, C.M. Carneiro, and M.J.O. Toledo Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains Memorias do Instituto Oswaldo Cruz 96 2001 1005 1011